erythropoietin biosimilar (GenBioPro)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameerythropoietin biosimilar (GenBioPro)
Drug Alias Nameerythropoietin
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenbiopro
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenbiopro
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A